GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pa Shun International Holdings Ltd (HKSE:00574) » Definitions » Quality Rank

Pa Shun International Holdings (HKSE:00574) Quality Rank


View and export this data going back to 2015. Start your Free Trial

What is Pa Shun International Holdings Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Pa Shun International Holdings Quality Rank Related Terms

Thank you for viewing the detailed overview of Pa Shun International Holdings's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Pa Shun International Holdings (HKSE:00574) Business Description

Traded in Other Exchanges
N/A
Address
229 Wufuqiao East Road, No. 608-616, Building 28, Longfor North Paradise Walk 2, Jinniu District, Sichuan Province, Chengdu, CHN
Pa Shun International Holdings Ltd is an investment holding company engaged in the manufacturing and distribution of pharmaceutical products. The business activity of the group is operated through Pharmaceutical distribution and Pharmaceutical manufacturing segment. Geographically all the activities are carried out in the PRC. The company derives the majority of revenue from the Pharmaceutical distribution segment which include sales of pharmaceutical products to wholesalers, franchise retail pharmacy chain stores and hospitals and other medical institutions in rural areas.
Executives
Zhongtai International Asset Management (singapore) Pte. Ltd. 2102 Investment manager
Arab Osman Mohammed 2104 Agent
Lai Wing Lun 2104 Agent
Win Win Stable No.3 Fund Sp 2106 Person having a security interest in shares
Zhongtai Innovation Capital Management Limited 2102 Investment manager
Chen Yenfei 2101 Beneficial owner
Praise Treasure Limited 2101 Beneficial owner